Safety and Efficacy of s-Citalopram in Patients with Co-Morbid Major Depression and Diabetes Mellitus

Publisher： Karger

E-ISSN： 1423-0224|54|4|208-214

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.54, Iss.4, 2007-04, pp. : 208-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Oral Escitalopram as Continuation Treatment of Intravenous Citalopram in Patients with Major Depressive Disorder

By  

Neuropsychobiology, Vol. 54, Iss. 4, 2007-04 ,pp. : 201-207

Karger

Access to resources Recommend Favorite

Evaluation of the Prophylactic Efficacy of Amitriptyline and Citalopram, Alone or in Combination, in Patients with Comorbidity of Depression, Migraine, and Tension-Type Headache

By  

Neuropsychobiology, Vol. 50, Iss. 4, 2004-11 ,pp. : 322-328

Karger

Access to resources Recommend Favorite

Supplementation with Eicosapentaenoic Omega-3 Fatty Acid Does Not Influence Serum Brain-Derived Neurotrophic Factor in Diabetes Mellitus Patients with Major Depression: A Randomized Controlled Pilot Study

By  

Neuropsychobiology, Vol. 63, Iss. 4, 2011-03 ,pp. : 219-223

Karger

Access to resources Recommend Favorite

Basal Prolactin Values Correlate with Response to Reboxetine Treatment in Major Depression, but Not with Response to Citalopram

By  

Neuropsychobiology, Vol. 51, Iss. 2, 2005-03 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

Neurotrophic Factor S100beta in Major Depression

By  

Neuropsychobiology, Vol. 44, Iss. 2, 2001-08 ,pp. : 88-90

Karger

Access to resources Recommend Favorite